These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15363105)

  • 1. Elevated midbrain serotonin transporter availability in mixed mania: a case report.
    Tolmunen T; Joensuu M; Saarinen PI; Mussalo H; Ahola P; Vanninen R; Kuikka J; Tiihonen J; Lehtonen J
    BMC Psychiatry; 2004 Sep; 4():27. PubMed ID: 15363105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
    Lehto SM; Tolmunen T; Kuikka J; Valkonen-Korhonen M; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Lehtonen J
    Neurosci Lett; 2008 Aug; 441(3):291-5. PubMed ID: 18588943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy.
    Lehto SM; Tolmunen T; Joensuu M; Saarinen PI; Valkonen-Korhonen M; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Lehtonen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):229-37. PubMed ID: 17884269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.
    Kugaya A; Sanacora G; Staley JK; Malison RT; Bozkurt A; Khan S; Anand A; Van Dyck CH; Baldwin RM; Seibyl JP; Charney D; Innis RB
    Biol Psychiatry; 2004 Oct; 56(7):497-502. PubMed ID: 15450785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain binding of [123I]nor-beta-CIT in atypical depression.
    Lehto S; Tolmunen T; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Lehtonen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1251-5. PubMed ID: 16644083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen.
    Saarinen PI; Lehtonen J; Joensuu M; Tolmunen T; Ahola P; Vanninen R; Kuikka J; Tiihonen J
    Am J Psychother; 2005; 59(1):61-73. PubMed ID: 15895769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents.
    Dahlström M; Ahonen A; Ebeling H; Torniainen P; Heikkilä J; Moilanen I
    Mol Psychiatry; 2000 Sep; 5(5):514-22. PubMed ID: 11032385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression.
    Joensuu M; Ahola P; Knekt P; Lindfors O; Saarinen P; Tolmunen T; Valkonen-Korhonen M; Vanninen R; Jääskeläinen T; Virtala E; Kuikka J; Tiihonen J; Lehtonen J
    Psychiatry Clin Neurosci; 2016 Jan; 70(1):34-41. PubMed ID: 26311446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
    Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
    Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
    Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
    Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
    Ruhé HG; Booij J; Reitsma JB; Schene AH
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
    Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
    Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
    Joensuu M; Tolmunen T; Saarinen PI; Tiihonen J; Kuikka J; Ahola P; Vanninen R; Lehtonen J
    Psychiatry Res; 2007 Feb; 154(2):125-31. PubMed ID: 17289353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.